A minimally invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest stages, according to a study presented May 15 at the American Thoracic Society International Conference in Denver.

Medrad has launched its next generation Intego PET Infusion System.

Medicsight has been granted FDA 510(k) clearance for its CT colonography (CTC) computer-aided detection (CAD) system.

I've seen enough, I'm not giving up on a miracle drug, sang U2 in their 2004 hit song. This week, the news centers on pharmacology and the FDAs oversight of certain drug therapies that were once touted as potential 'miracle drugs.'

Maquet Cardiovascular has received FDA 510(k) clearance, as well as European CE mark approval, to market its Cardioroot aortic graft, a one-piece design, aortic root graft.

Flurpiridaz F 18 injection, a myocardial perfusion imaging (MPI) PET agent, appears to be safe and superior to SPECT with respect to image quality, diagnostic certainty and sensitivity for detection of coronary artery disease (CAD), according to a Phase II late-breaking clinical trial presented May 17 at the International Conference of Non-Invasive Cardiovascular Imaging (ICNC) in Amsterdam.

iCAD and Matakina have entered into a distribution partnership to provide radiologists an objective breast density assessment tool with computer-aided detection (CAD) systems.

Physicians and public health experts from multiple healthcare specialties met in Washington, D.C. this month to work toward a comprehensive approach to battling lung cancer in the U.S., at a forum titled "Out of the Shadows:  Lung Cancer and Screening."